Mereo BioPharma Group plc (MREO) stock
MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.29+0.01 (+5.39%)
Close on Nov 18, 2026Market cap $46.20MP/E –Yield –
Mereo BioPharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Mereo BioPharma's price to sales ratio was 85.6× on Apr 30, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 85.6× | −357.0 |
| 2025 | Jan 31, 2025 | 442.5× | +387.4 |
| 2024 | Jul 31, 2024 | 55.1× | – |
See a number that looks wrong?